NVR UL7 (Piqray 150 mg)
Generic Name: alpelisib
Pill with imprint NVR UL7 is Pink, Elliptical/Oval and has been identified as Piqray 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Piqray is used in the treatment of breast cancer; breast cancer, male and belongs to the drug class PI3K inhibitors. Piqray 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR UL7
Piqray
- Generic Name
- alpelisib
- Imprint
- NVR UL7
- Strength
- 150 mg
- Color
- Pink
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- PI3K inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0708
More about Piqray (alpelisib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (2)
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: PI3K inhibitors
- FDA approval history
Patient resources
- Drug Information
- Piqray 200MG Daily Dose (Advanced Reading)
- Piqray 250MG Daily Dose (Advanced Reading)
- Piqray 300MG Daily Dose (Advanced Reading)
- Piqray 200MG Daily Dose
- Piqray 300MG Daily Dose
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.